Stock FBIO FORTRESS BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Fortress Biotech, Inc.

Equities

FBIO

US34960Q3074

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-02 EDT 		5-day change 1st Jan Change
1.8 USD +3.45% Intraday chart for Fortress Biotech, Inc. +4.65% -40.20%
04-03 North American Morning Briefing : Powell Awaited -2- DJ
04-02 Certain Warrants of Fortress Biotech, Inc. are subject to a Lock-Up Agreement Ending on 2-APR-2024. CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Fortress Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Eric Rowinsky Announces Not Stand for Re-Election to the Board of Fortress Biotech, Inc
Fortress Biotech Prices $11 Million Offering of Stock, Warrants; Shares Sink in Early Trading
Top Midday Gainers
Fortress Biotech Insider Bought Shares Worth $2,664,776, According to a Recent SEC Filing
Fortress Biotech Insider Bought Shares Worth $249,999, According to a Recent SEC Filing
Fortress Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Wall Street Set to Open Slightly Higher as Investors Parse Powell Remarks
Top Premarket Decliners
Fortress Biotech Begins Public Offering of Units
Journey Medical Corporation Announces Data from Bioavailability Study of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 Mg) Vs. Solodyn (Minocycline Hydrochine Hydrochloride Extended-Release Tablets, 105 Mg)
Fortress Biotech Announces 1-for-15 Reverse Stock Split
Fortress Biotech CEO Rosenwald Buys 20,000 Shares for $210,900
Fortress Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Fortress Biotech Unit Urica Says Study of Dotinurad Shows Comparable Profile Between Healthy US, Japanese Subjects
Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Fortress Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Fortress Biotech Closes $13.9 Million Registered Direct Offering
Fortress Biotech to Raise $13.9 Million in Registered Direct Offering
Fortress Biotech, Inc. Appoints Lucy Lu, M.D., to Its Board of Directors
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FBIO Stock
  4. News Fortress Biotech, Inc.
  5. Other languages